BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28002655)

  • 21. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.
    Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y
    Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor.
    Kim JM; Kwon CH; Joh JW; Kang ES; Park JB; Lee JH; Kim SJ; Paik SW; Lee SK; Kim DW
    J Hepatol; 2013 Dec; 59(6):1215-22. PubMed ID: 23928408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation.
    Kanazawa H; Fukuda A; Mali VP; Rahayatri TH; Hirata Y; Sasaki K; Uchida H; Shigeta T; Sakamoto S; Matsumoto K; Kasahara M
    Pediatr Transplant; 2016 May; 20(3):401-7. PubMed ID: 27012966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation.
    Tajima T; Hata K; Haga H; Kusakabe J; Kageyama S; Yurugi K; Hishida R; Zhao X; Nishikori M; Nagao M; Takaori-Kondo A; Uemoto S; Hatano E
    Liver Transpl; 2023 Jul; 29(7):711-723. PubMed ID: 36749821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
    Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
    Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fourteen successful consecutive cases of ABO-incompatible living donor liver transplantation: new simplified intravenous immunoglobulin protocol without local infusion therapy.
    Kim JD; Choi DL; Han YS
    Transplant Proc; 2014 Apr; 46(3):754-7. PubMed ID: 24767341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
    Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.
    Iso Y; Sawada T; Kita J; Shiraki T; Sakuraoka Y; Kato M; Shimoda M; Kubota K
    Hepatogastroenterology; 2013 Oct; 60(127):1624-6. PubMed ID: 24634932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab administration one week before ABO-incompatible liver transplantation due to drug-induced acute liver failure with hepatic coma: a case report.
    Sasaki K; Kobayashi S; Iwagami Y; Yamada D; Tomimaru Y; Noda T; Takahashi H; Doki Y; Eguchi H
    Clin J Gastroenterol; 2023 Oct; 16(5):709-714. PubMed ID: 37470968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution.
    Lee J; Lee JG; Lee JJ; Kim MS; Ju MK; Choi GH; Choi JS; Kim SI; Joo DJ
    Transplant Proc; 2015 Apr; 47(3):723-6. PubMed ID: 25891718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation.
    Oh J; Kim JM
    Clin Mol Hepatol; 2020 Jan; 26(1):1-6. PubMed ID: 30909688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-mediated rejection after ABO-incompatible pediatric living donor liver transplantation for propionic acidemia: A case report.
    Honda M; Sakamoto S; Sakamoto R; Matsumoto S; Irie T; Uchida K; Shimata K; Kawabata S; Isono K; Hayashida S; Yamamoto H; Endo F; Inomata Y
    Pediatr Transplant; 2016 Sep; 20(6):840-5. PubMed ID: 27436684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab.
    Lee SD; Kim SH; Kong SY; Kim YK; Park SJ
    Transpl Immunol; 2015 Jan; 32(1):29-34. PubMed ID: 25449537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
    Sugiyama K; Hyodo Y; Aikawa A
    Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Yoon YI; Kim N
    J Hepatol; 2014 Sep; 61(3):575-82. PubMed ID: 24801413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange.
    Kawagishi N; Satoh K; Enomoto Y; Akamatsu Y; Sekiguchi S; Fukumori T; Fujimori K; Satomi S
    Transplant Proc; 2005 Mar; 37(2):1205-6. PubMed ID: 15848670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Status of ABO-incompatible Liver Transplantation.
    Egawa H; Ohdan H; Saito K
    Transplantation; 2023 Feb; 107(2):313-325. PubMed ID: 35849558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.